We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
-8.2%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$103M
AUM Growth
-$16.3M
Cap. Flow
-$2.39M
Cap. Flow %
-2.33%
Top 10 Hldgs %
47.22%
Holding
63
New
5
Increased
18
Reduced
32
Closed
2
Avg Time Held
12.5 quarters
Top 10 Avg Time Held
4.2 quarters
Top 20 Avg Time Held
8.6 quarters

Top Buys

Rank Stock Value
1
UPLD icon
Upland Software
UPLD
+$2.01M
2
FIVN icon
FIVE9
FIVN
+$1.81M
3
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1.47M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$1.06M
5
TECH icon
Bio-Techne
TECH
+$334K

Top Sells

Rank Stock Value
1
KTWO icon
K2M Group Holdings, Inc
KTWO
+$4.3M
2
OCLR
Oclaro Inc.
OCLR
+$3.04M
3
XENT
Intersect ENT, Inc
XENT
+$731K
4
HDP
Hortonworks, Inc.
HDP
+$438K
5
CY
Cypress Semiconductor
CY
+$301K

Sector Composition

Rank Sector Weight
1 Healthcare 43.4%
2 Technology 40.17%
3 Financials 3.45%
4 Miscellaneous 2.81%
5 Consumer Discretionary 2.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
VCEL icon
1
Vericel Corp
VCEL
$2.06B
$6.91M 6.74%
397,364
-2,684
-0.7% -$40.2K
2017 Q1
7 quarters
TWLO icon
2
Twilio
TWLO
$42.9B
$6.03M 5.88%
67,495
-681
-1% -$55.3K
2017 Q4
4 quarters
IDTI
3
DELISTED
Integrated Device Technology I
IDTI
$5.93M 5.78%
122,384
-2,096
-2% -$99K
2013 Q2
22 quarters
NEO icon
4
NeoGenomics
NEO
$2.08B
$5.22M 5.09%
413,607
-1,226
-0.3% -$18.3K
2013 Q2
22 quarters
XENT
5
DELISTED
Intersect ENT, Inc
XENT
$4.55M 4.44%
161,587
-24,974
-13% -$731K
2015 Q1
15 quarters
ATRC icon
6
AtriCure
ATRC
$2.84B
$4.37M 4.27%
142,882
-1,386
-1% -$43.2K
2013 Q2
22 quarters
IMPV
7
DELISTED
Imperva, Inc.
IMPV
$4.2M 4.1%
75,487
-465
-0.6% -$25.3K
2016 Q4
8 quarters
CY
8
DELISTED
Cypress Semiconductor
CY
$3.81M 3.72%
299,501
-22,736
-7% -$301K
2018 Q1
3 quarters
OMCL icon
9
Omnicell
OMCL
$1.64B
$3.8M 3.7%
61,985
-265
-0.4% -$17.9K
2013 Q2
22 quarters
CYBR icon
10
DELISTED
CyberArk
CYBR
$3.58M 3.49%
48,281
-172
-0.4% -$12.3K
2016 Q4
8 quarters
CVLT icon
11
Commault Systems
CVLT
$6.54B
$3.31M 3.23%
55,953
-559
-1% -$33K
2014 Q2
18 quarters
SRGA
12
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$3.21M 3.13%
28,926
-982
-3% -$128K
2013 Q2
22 quarters
HDP
13
DELISTED
Hortonworks, Inc.
HDP
$3.07M 2.99%
212,606
-25,407
-11% -$438K
2018 Q2
2 quarters
FNSR
14
DELISTED
Finisar Corp
FNSR
$2.99M 2.92%
138,372
-621
-0.4% -$12.4K
2013 Q2
22 quarters
PODD icon
15
Insulet
PODD
$9.53B
$2.94M 2.87%
37,093
+21
+0.1% +$1.78K
2014 Q2
18 quarters
HZNP
16
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.86M 2.79%
146,351
+54,162
+59% +$1.06M
2017 Q2
6 quarters
NXTM
17
DELISTED
NxStage Medical Inc.
NXTM
$2.79M 2.72%
97,465
-1,400
-1% -$39.8K
2013 Q4
20 quarters
LGND icon
18
Ligand Pharmaceuticals
LGND
$6.01B
$2.62M 2.56%
31,002
-220
-0.7% -$23.5K
2013 Q2
22 quarters
SUPN icon
19
Supernus Pharmaceuticals
SUPN
$2.47B
$2.52M 2.46%
75,962
+34,262
+82% +$1.47M
2016 Q2
10 quarters
MXL icon
20
MaxLinear
MXL
$8.27B
$2.22M 2.16%
125,896
-3,833
-3% -$70.2K
2014 Q3
17 quarters
FIVN icon
21
FIVE9
FIVN
$2.72B
$1.97M 1.92%
+45,015
New +$1.81M
2018 Q4
0 quarters
UPLD icon
22
Upland Software
UPLD
$10.2M
$1.82M 1.77%
+6,689
New +$2.01M
2018 Q4
0 quarters
AAPL icon
23
Apple
AAPL
$4.99T
$1.18M 1.15%
29,848
+276
+0.9% +$13.4K
2016 Q3
9 quarters
SPY icon
24
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$1.11M 1.08%
4,450
– –
2013 Q2
22 quarters
MAR icon
25
Marriott International
MAR
$95.8B
$1.02M 0.99%
9,369
-406
-4% -$46.6K
2013 Q2
22 quarters
1
2 3

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Kopp Investment Advisors held 63 positions worth $103M, down 14% from $119M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Kopp Investment Advisors's Q4 2018 filing shows 5 new, 18 increased, 32 reduced and 2 closed positions. Its largest new stake was Upland Software: 6,689 shares worth $1.82M. The largest sale was K2M Group Holdings, Inc, an estimated $4.3M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 47% a quarter earlier, followed by Technology and Financials.

  • Kopp Investment Advisors's largest Q4 2018 buy was Upland Software: 6,689 shares worth $1.82M.
  • Kopp Investment Advisors added most to Supernus Pharmaceuticals in Q4 2018, an estimated $1.47M increase.
  • Kopp Investment Advisors's biggest Q4 2018 reduction was Intersect ENT, Inc, cutting an estimated $731K.
  • Kopp Investment Advisors fully exited K2M Group Holdings, Inc in Q4 2018, selling an estimated $4.3M.
  • Kopp Investment Advisors's ten largest holdings make up 47% of its $103M portfolio in Q4 2018.
  • Kopp Investment Advisors opened 5 new positions and closed 2 in Q4 2018.
  • Kopp Investment Advisors's portfolio value fell 14% quarter-over-quarter to $103M.

Based on Kopp Investment Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.